Trimetazidine
Trimetazidine is a pharmaceutical drug with 21 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
8
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
11 of 11 finished
0.0%
0 ended early
0
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI
"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"
Metoprolol and Trimetazidine for Coronary Heart Disease With Angina
Benefits of Trimetazidine in MASLD Patients
Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
Clinical Trials (21)
Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI
"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"
Metoprolol and Trimetazidine for Coronary Heart Disease With Angina
Benefits of Trimetazidine in MASLD Patients
Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis
The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease
The Effects of TMZ on Diabetic Nephropathy
Effect of Trimetazidine on Radiotherapy-induced Heart Damage.
Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF
TRimetazidine for acUte on Chronic Liver Failure STudy
Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19
Trimetazidine as an Adjunct to Enhance Clopidogrel Response.
The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)
Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction
Trimetazidine in Pulmonary Artery Hypertension
Trimetazidine Therapy in Hypertrophic Cardiomyopathy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21